Fundz

Gryphon Bio Appoints Anthony DeLizza as Chief Business Officer

PRIVATEJan 13, 2025

Position

Chief Business Officer

Company

Gryphon Bio

Anthony DeLizza
adelizza@gryphonbio.com
San FranciscoBiotechnologyHealth Care

Description

Gryphon Bio, Inc has appointed Anthony DeLizza as Chief Business Officer responsible for the oversight of Gryphon's biomarker validation studies, product development, FDA product clearance, and commercialization. Mr. DeLizza brings a long career in commercializing med-tech solutions including laboratory, point-of-care diagnostics, and medical devices.

Quick answer

Gryphon Bio Appoints Anthony DeLizza as Chief Business Officer (January 13, 2025). Gryphon Bio is based in San Francisco, California, United States.

Who is the new Chief Business Officer at Gryphon Bio?
Gryphon Bio named Anthony DeLizza Chief Business Officer, announced January 13, 2025.
What did Gryphon Bio announce on January 13, 2025?
Gryphon Bio, Inc has appointed Anthony DeLizza as Chief Business Officer responsible for the oversight of Gryphon's biomarker validation studies, product development, FDA product clearance, and commercialization. Mr. DeLizza brings a long career in commercializing med-tech solutions including laboratory, point-of-care diagnostics, and medical devices.
What does Gryphon Bio do?
Gryphon Bio is an early-stage company created to harness our co-founders' discovery of unexpected waves of 1000s of brain molecules in the blood as novel therapeutic targets and temporal blood biomarkers (brain-specific...
Where is Gryphon Bio based?
Gryphon Bio is based in San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
The Bladder Cancer Advocacy Network (January 13, 2025), MedQuest Associates (January 13, 2025), OSE Immunotherapeutics (January 13, 2025) and QuantHealth (January 13, 2025) also announced leadership changes within 45 days of Gryphon Bio.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Gryphon Bio, and when

A new leader at Gryphon Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Gryphon Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gryphon Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gryphon Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gryphon Bio

Location

San Francisco, California, United States

About

Gryphon Bio is an early-stage company created to harness our co-founders' discovery of unexpected waves of 1000s of brain molecules in the blood as novel therapeutic targets and temporal blood biomarkers (brain-specific proteins with blood levels that change over time like waves in the ocean). They made these discoveries over more than 20 years of “brain proteomic” research, the large-scale measurement of proteins in the brain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gryphon Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Anthony
Likely contact at this company
••••••••@••••••••

See Anthony's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Gryphon Bio's next move

Learn about Strategic plan

Gryphon Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.